Simvastatin lowers reactive oxygen species level by Nrf2 activation via PI3K/Akt pathway

被引:62
作者
Chartoumpekis, Dionysios [1 ]
Ziros, Panos G. [1 ]
Psyrogiannis, Agathoklis [1 ]
Kyriazopoulou, Venetsana [1 ]
Papavassiliou, Athanasios G. [2 ]
Habeos, Ioannis G. [1 ]
机构
[1] Univ Patras, Sch Med, Dept Internal Med, Patras 26500, Greece
[2] Univ Athens, Sch Med, Dept Biol Chem, GR-11527 Athens, Greece
关键词
Nrf2; Simvastatin; Reactive oxygen species; HMG-CoA reductase inhibitors; PI3K/Akt; HEME OXYGENASE-1; OXIDATIVE STRESS; STATINS; CELLS; EXPRESSION; GENES; LIVER; AKT;
D O I
10.1016/j.bbrc.2010.04.117
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The beneficial effects of HMG-CoA (3-hydroxy-3-methyl-glutaryl-CoA) reductase inhibitors (statins) have been attributed not only to their cholesterol lowering effect but also to their pleiotropic actions and especially to their anti-oxidant activity. Nrf2 (NF-E2-related factor 2) is a transcription factor that orchestrates the transcriptional response of cells to oxidative stressors and electrophilic xenobiotics. In this study, primary mouse embryonic fibroblasts from wild type or Nrf2 knock out C57B16J mice and ST-2 cells were used to investigate the implication of Nrf2 in the mediation of the anti-oxidant effects of statins and the possible involvement of PI3K/Akt pathway in this process. We show for the first time that simvastatin lowers reactive oxygen species (ROS) by activating Nrf2 through the PI3K/Akt pathway. (C) 2010 Elsevier Inc. All rights reserved.
引用
收藏
页码:463 / 466
页数:4
相关论文
共 25 条
  • [1] Antioxidative effects of statins
    Adam, Oliver
    Laufs, Ulrich
    [J]. ARCHIVES OF TOXICOLOGY, 2008, 82 (12) : 885 - 892
  • [2] Akt is a neutral amplifier for Th cell differentiation
    Arimura, Y
    Shiroki, F
    Kuwahara, S
    Kato, H
    Dianzani, U
    Uchiyama, T
    Yagi, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (12) : 11408 - 11416
  • [3] Statins and modulation of oxidative stress
    Beltowski, J
    [J]. TOXICOLOGY MECHANISMS AND METHODS, 2005, 15 (02) : 61 - 92
  • [4] Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance
    Beyer, Tobias A.
    Xu, Weihua
    Teupser, Daniel
    Keller, Ulrich auf dem
    Bugnon, Philippe
    Hildt, Eberhard
    Thiery, Joachim
    Kan, Yuet Wai
    Werner, Sabine
    [J]. EMBO JOURNAL, 2008, 27 (01) : 212 - 223
  • [5] Simvastatin improves endothelial function in spontaneously hypertensive rats through a superoxide dismutase mediated antioxidant effect
    Carneado, J
    de Sotomayor, MA
    Perez-Guerrero, C
    Jimenez, L
    Herrera, MD
    Pamies, E
    Martin-Sanz, MDV
    Stiefel, P
    Miranda, M
    Bravo, L
    Marhuenda, E
    [J]. JOURNAL OF HYPERTENSION, 2002, 20 (03) : 429 - 437
  • [6] HMG-CoA reductase inhibitors upregulate heme oxygenase-1 expression in murine RAW264.7 macrophages via ERK, p38 MAPK and protein kinase G pathways
    Chen, JC
    Huang, KC
    Lin, WW
    [J]. CELLULAR SIGNALLING, 2006, 18 (01) : 32 - 39
  • [7] CHERYL CLM, 2005, BASIC CELL CULTURE P
  • [8] Age-Accelerated Atherosclerosis Correlates With Failure to Upregulate Antioxidant Genes
    Collins, Alan R.
    Lyon, Christopher J.
    Xia, Xuefeng
    Liu, Joey Z.
    Tangirala, Rajendra K.
    Yin, Fen
    Boyadjian, Rima
    Bikineyeva, Alfiya
    Pratico, Domenico
    Harrison, David G.
    Hsueh, Willa A.
    [J]. CIRCULATION RESEARCH, 2009, 104 (06) : e42 - E54
  • [9] The antioxidant effects of statins
    Davignon, J
    Jacob, RF
    Mason, RP
    [J]. CORONARY ARTERY DISEASE, 2004, 15 (05) : 251 - 258
  • [10] HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway
    Dimmeler, S
    Aicher, A
    Vasa, M
    Mildner-Rihm, C
    Adler, K
    Tiemann, M
    Rütten, H
    Fichtlscherer, S
    Martin, H
    Zeiher, AM
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2001, 108 (03) : 391 - 397